| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 480 | 34.040 | 81.899 | 92.818 |
| Total Income - EUR | - | - | - | - | - | - | 19.778 | 37.393 | 81.902 | 92.820 |
| Total Expenses - EUR | - | - | - | - | - | - | 24.086 | 43.806 | 77.081 | 79.820 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -4.309 | -6.413 | 4.821 | 13.000 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -4.313 | -6.753 | 4.002 | 10.607 |
| Employees | - | - | - | - | - | - | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Fitofarm Crivăț S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 4.893 | 1.743 | 145 | 0 |
| Current Assets | - | - | - | - | - | - | 12.006 | 16.569 | 27.249 | 35.435 |
| Inventories | - | - | - | - | - | - | 10.886 | 16.215 | 21.391 | 30.419 |
| Receivables | - | - | - | - | - | - | 410 | 235 | 1.849 | 1.167 |
| Cash | - | - | - | - | - | - | 710 | 118 | 4.009 | 3.849 |
| Shareholders Funds | - | - | - | - | - | - | -4.342 | -11.109 | -7.074 | 3.572 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 18.025 | 29.559 | 34.575 | 31.970 |
| Income in Advance | - | - | - | - | - | - | 3.343 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Fitofarm Crivăț S.r.l.